You dont have javascript enabled! Please enable it! Guidance 058 – Purified Water and Water for Injection System Commissioning and Qualification Sampling Plans Pharmaceuticals quality assurance & validation procedures GMPSOP

Guidance 058 – Purified Water and Water for Injection System Commissioning and Qualification Sampling Plans

Introduction

This guidance recommends sampling locations, frequencies and testing activities associated with the commissioning and qualification of Purified Water (PW) and Water for Injection (WFI) Systems.

This guidance identifies the sampling location, frequency and testing activities based on recommended guidelines for supporting the commissioning and qualification for PW and WFI. This guidance is supplemental to Guidance 078 ‘Water Purification, Storage, and Distribution for Pharmaceutical Production’ and consistent with current industry practices. The commissioning and/or qualification activities associated with other grades of water (e.g., potable) are outside the scope of this document. Ongoing operations (i.e. routine monitoring) after qualification activities are also outside of the scope of this guidance.

Recommendations & Rationale

The results of the commissioning and qualification are designed to demonstrate that the equipment, personnel and operating procedures are capable of consistently providing water meeting the necessary water quality requirements.

The testing of PW and WFI Systems include Pre-Treatment, Generation and associated Distribution Systems starting with commissioning activities and continuing through the three phases of qualification studies.

Commissioning (approximately 1-5 days)

Sampling and monitoring of the Pre-treatment, Generation and Distribution Systems for PW and WFI Systems during commissioning are considered Good Engineering Practice. These activities

help to define operational and maintenance practices and procedures that will be challenged later during qualification. The sampling and testing activities include chemical testing as appropriate

for unit operation and microbial testing to identify the indigenous microbial bioburden of the system. Typically, the duration of commissioning activities may vary depending upon the complexity and size of the system. Once the entire system is operating, each unit of operation should be tested at least once during the commissioning phase.

For further detailed information regarding the specific sampling locations, associated testing frequencies and type of testing for Commissioning and Qualification activities for the PW and

WFI systems, then please refer to Tables #1-5.

Phase 1 Qualification (approximately 1 month)

The Phase 1 Qualification study lasts a minimum of one month with samples being taken on a daily basis. The requirement is to meet the expectations of 2 to 4 weeks per current industry practice as well as per the FDA Guide to Inspections of High Purity Water Systems for the duration of daily sampling and testing for Phase 1 activitiesThe Phase 1 activities are performed to demonstrate that the production and delivery of water consistently meets the specified compendial requirements. It is also very important during Phase 1 activities to finalize appropriate operating ranges for critical process parameters as well as to finalize Standard Operating Procedures (SOPs) for routine system operation, cleaning and maintenance.

 Phase 2 Qualification (approximately 1 month)

The Phase 2 activities typically last the same duration as Phase 1, which is one month. The sampling and testing frequency are nearly identical to the activities in Phase 1. The purpose of Phase 2 is to further demonstrate consistent production and delivery of water of the required quality within the established ranges when using SOPs. There are some equipment systems which require on-line measurement (e.g., measurement of conductivity when utilizing Reverse Osmosis (RO). It is an acceptable practice to utilize only on-line measurement testing results for the routine release testing.

Data resulting from the on-line measurement testing must be treated as primary data.

 Phase 3 Qualification (approximately 10 months)

The Phase 3 portion of the water system qualification activities continue for the remaining balance of the year (approximately 10 months). Collectively, the entire Qualification process consisting of Phase 1, Phase 2, and Phase 3 is an extended study of the system for a period of one year. A one year time frame allows for the system to be challenged by evaluating its effectiveness of delivering water of acceptable quality despite seasonal variations in the raw water feed to the system.

Typically, the Phase 3 sampling plan is reduced in frequency from the Phase 1 and Phase 2 schedule with the sampling and testing activities being consistent with the routine monitoring program post-validation. At a minimum the sample schedule for Phase 3 testing must be consistent with any specified sampling requirements indicated within Guidance 078 Water Purification, Storage, and Distribution for Pharmaceutical Production.

 Risk Based Approach:

A risk based approach to commissioning and qualification may be utilized to develop the sampling strategy. For example, impact assessments may be utilized to determine what components or functions of the PW or WFI System are considered critical.

A water quality attribute may be defined as critical based on the need to meet a specific compendia specification and is not further affected by additional downstream operating steps. For example, conductivity is a critical attribute that is measured at the outlet of a PW Generation System (e.g., outlet of the Continuous Electrodeionization (CEDI) or Reverse Osmosis (RO)) for verifying the results satisfactorily meet compendia limits. Sampling the conductivity at this point would occur during commissioning and qualification activities.

Non-critical quality attributes (e.g., outlet of the media filters,) are tested only during commissioning. Thus they may become part of an on-going routine monitoring program subject to Good Engineering Practices (GEP) which may include routine monitoring tests to assure proper maintenance and operation of the System (e.g., regeneration of resin beds, sanitization of equipment, etc.). This on-going monitoring on non-critical attributes is not to be a part of the qualification studies.